Citadel Advisors
ELOS

Citadel Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Citadel Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,000
Closed -$175K – 8509
2017
Q2 		$175K Buy
+16,000
New +$175K ﹤0.01% 6645
2016
Q1 		– Sell
-200
Closed -$2K – 8814
2015
Q4 		$2K Sell
200
-200
-50% -$1.52K ﹤0.01% 8594
2015
Q3 		$3K Sell
400
-7,200
-95% -$69.2K ﹤0.01% 8717
2015
Q2 		$81K Sell
7,600
-100
-1% -$1.17K ﹤0.01% 7295
2015
Q1 		$95K Buy
7,700
+5,300
+221% +$58.7K ﹤0.01% 6878
2014
Q4 		$22K Buy
+2,400
New +$23.1K ﹤0.01% 7748
2014
Q3 		– Sell
-200
Closed -$2K – 8642
2014
Q2 		$2K Sell
200
-1,000
-83% -$10.8K ﹤0.01% 7850
2014
Q1 		$15K Sell
1,200
-300
-20% -$3.55K ﹤0.01% 7394
2013
Q4 		$18K Sell
1,500
-500
-25% -$5.2K ﹤0.01% 6529
2013
Q3 		$17K Buy
2,000
+1,400
+233% +$12.1K ﹤0.01% 6312
2013
Q2 		$5K Buy
+600
New +$5.37K ﹤0.01% 6349

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Citadel Advisors's ELOS Position: Q2 2017 in Review

Citadel Advisors sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 11,835 shares — an estimated $130K sold.

Citadel Advisors first reported a position in ELOS in Q2 2013 and held it in 12 quarters. The position peaked at $2.28M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Citadel Advisors reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 11,835 Syneron Medical Ltd shares in Q2 2017, an estimated $130K.
  • Citadel Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 12 quarters.
  • Citadel Advisors's Syneron Medical Ltd position peaked at $2.28M in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.